Biologics Breakthrough: Cutting Costs While Expanding Global Reach
June 23, 2026
BioProcess Theatre
Type: BioProcess Session
What manufacturing innovations have delivered the most significant cost reductions while maintaining product quality in your biologics operations?
How are you balancing the capital investment required for continuous manufacturing against the long-term cost savings and efficiency gains?
Which specific single-use technologies have provided the best combination of cost reduction and manufacturing flexibility in your experience?
What strategies have most effectively reduced cold chain costs while ensuring product integrity during global distribution?
How are you leveraging data analytics to identify and eliminate hidden cost drivers in your biologics manufacturing and distribution networks?
What approaches have successfully reduced regulatory compliance costs without compromising quality or patient safety?
How do you optimize the trade-off between centralized manufacturing efficiency and the cost benefits of regional production closer to end markets?


